Tag
psychedelic research
- Puerto Rico governor signs executive order for psychedelic therapy research
- American DEA boosts psychedelic drug production quotas
- Woke Pharma and Swinburne U partner for Australia's biggest psilocybin trial
- European Psychiatric Association aligns with PAREA: a multi-organization psychedelic partnership
- Silo Pharma prepares pre‑IND package for FDA on novel ketamine formulation
- PharmAla Biotech becomes first public company producing GMP MDMA
- Recent acquisitions help Numinus bolster revenue 240 per cent year-over-year
- Delic Labs granted permission to study psychedelics including LSD, MDMA
- Numinus approved to study ayahuasca and San Pedro in Canada
- Numinus develops in‑house tests to detect compounds in psychedelic mushrooms
- DEA proposes hiking Schedule I drug production for medical research
- More Canadians, Americans open to psychedelic therapy, surveys show
- Numinus to test natural psilocybin safety in Phase 1 trial
- Attend next week's psychedelics legalization debate
- Psilocybin treats depression as well as common antidepressant: study
- Australia to spend $14.5M on psychedelic drug trials
- CaaMTech close to winning patent to combine weed and psychedelics
- Psilocybin therapy 4 times more effective than antidepressants: study
- Havn wants to turn hard lessons into psychedelic gold
- UC Berkeley's new psychedelic research centre wants to change your mind
- Mushroom company Mydecine acquires veteran-focused psychedelic firm
- Psychedelic treatment firm enters NIH research deal